A qualitative study to explore the links between IPV and HIV-related health among pregnant women and service providers in Johannesburg, South Africa. Ensuring PMTCT adherence is crucial as more countries move towards Option B+ policy to ensure all HIV + pregnant women are initiated on life-long ART. Many structural drivers including stigma, poverty, transport costs [read more …]
Publications for Option B Plus
Health Outcomes and Cost Impact of the New WHO 2013 Guidelines on Prevention of Mother-to-Child Transmission of HIV in Zambia.
This study was conducted in Zambia to examine health outcomes and cost impacts of the shift from 2010 option A to WHO 2013 recommendation for prevention of mother to child transmission of HIV. A decision analytic model was developed based on the national health system perspective and estimated risk and number of cases of HIV [read more …]
This study estimated the additional costs and effectiveness of Option B+ through a deterministic model to simulate births, breastfeeding, and HIV infection in women in four countries, Kenya, Zambia, South Africa, and Vietnam. Findings showed that Option B+ was the most cost-effective strategy costing between $6000 and $23 000 per infection averted compared with Option A. [read more …]
Women’s Preferences Regarding Infant or Maternal Antiretroviral Prophylaxis for Prevention of Mother-To-Child Transmission of HIV during Breastfeeding and Their Views on Option B+ in Dar es Salaam, Tanzania.
A qualitative study was conducted in Dar es Salaam, Tanzania to explore women’s preferences for Option A versus B for PMTCT and their views on Option B+. Focused group discussions were conducted with 27 pregnant women with unknown HIV status and 31 HIV-infected pregnant and postpartum women. Findings showed that most participant preferred Option B [read more …]